Expanded Access Program of AMTAGVI that is Out of Specification for Commercial Release
- Sponsor:
- Iovance Biotherapeutics, Inc.
- Sponsor Study ID:
- IOV-EAP-402
- CTO #:
- 104272
- NCT Number:
- NCT05398640
- Phase:
- N/A
- Protocol Type:
- Treatment
- Age Group:
- Adults
- Disease Sites:
- Melanoma, Skin
- Study Objectives:
- To provide access to OOS AMTAGVI.
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Jenkins, Russell W, at jenkinr@musc.edu
- Study Coordinator, Newman, Eva, at newmanev@musc.edu
Trial opened at the following institutions:
Medical University of South Carolina